Celltrion’s COVID-19 Treatment Regdanvimab Is Approved In Korea

Follows Conditional Approval In February From Korean Regulator

 
• By Dean Rudge
South Korea flag waving against clean blue sky, close up, isolated with clipping path mask alpha channel transparency
The EMA is currently evaluating regdanvimab • Source: Shutterstock

More from Products

More from Generics Bulletin